NextCure, Inc. Quarterly Deferred Tax Assets, Valuation Allowance in USD from Q4 2018 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
NextCure, Inc. quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from Q4 2018 to Q4 2023.
  • NextCure, Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending December 31, 2023 was $99M, a 24.1% increase year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $99M +$19.2M +24.1% Dec 31, 2023 10-K 2024-03-21
Q4 2022 $79.7M +$22M +38.2% Dec 31, 2022 10-K 2024-03-21
Q4 2021 $57.7M +$20.2M +53.7% Dec 31, 2021 10-K 2023-03-02
Q4 2020 $37.6M +$11.9M +46.5% Dec 31, 2020 10-K 2022-03-03
Q4 2019 $25.6M +$10.1M +65.1% Dec 31, 2019 10-K 2021-03-04
Q4 2018 $15.5M Dec 31, 2018 10-K 2020-03-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.